COMMUNIQUÉS West-GlobeNewswire

Tristan Imbert co-opted as Independent Director
10/12/2025
Press Release Paris – December 10, 2025 - EUROAPI today announces that, following the resignation of Rodolfo Savitzky from his position as Independent Director (effective December 31, 2025) 1 , and upon the [...]
Tristan Imbert coopté Administrateur Indépendant
10/12/2025
Communiqué de presse Paris - Le 10 décembre 2025 - EUROAPI annonce aujourd’hui qu’à la suite de la démission de Rodolfo Savitzky de son poste d’Administrateur Indépendant (effective au 31 décembre 2025) 1 et sur [...]
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
10/12/2025
IXCHIQ ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after twelve months in both dose groups, although more [...]
Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants
10/12/2025
IXCHIQ ® a été bien toléré par les enfants âgés d’un à onze ans indépendamment de la dose de vaccin reçue ou d’une précédente infection au virus du chikungunya Les niveaux d’anticorps demeurent élevés après douze mois [...]
Une utilisation précoce de CARVYKTI®▼ (ciltacabtagène autoleucel) a permis d’obtenir des rémissions durables sans traitement pendant 2,5 ans chez des patients atteints d’un myélome multiple en rechute ou réfractaire
10/12/2025
Les données de suivi issues de l’étude CARTITUDE-4 révèlent qu’au moins 80 pour cent des patients à risque standard traités n’ont présenté aucune progression de la maladie et n’ont reçu aucun traitement après une [...]
EmblemHealth Announces New Agreement with the Hospital for Special Surgery
10/12/2025
City workers will retain access to the country’s highest-ranked orthopedic center NEW YORK, Dec. 10, 2025 (GLOBE NEWSWIRE) -- With the New York City Employees (NYCE) PPO health plan going live January 1, EmblemHealth [...]
Priority Partners Opening Two More Free Mini-Pantries in Maryland
10/12/2025
New Cupboards Target Food Insecurity In Time for Holidays HANOVER, Md., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Priority Partners’ Cupboards Project is celebrating the season of giving with the launch of two new free self- [...]
Akira Botanicals Announces Farm-Direct, Compliant CBD Relief Oils and Salves as Federal Hemp Rules Shift
10/12/2025
Akira Botanicals highlights its seed-to-bottle production model and its Sleep Oil with CBN, Energy Oil with THCV, and Relief Salves as the hemp industry adapts to new federal requirements. Marshall, NC, Dec. 10, 2025 ( [...]
4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology
10/12/2025
Physics-informed, deterministic biomarkers from routine H&E slides run natively on AMD EPYC™ CPUs — enabling reproducible AI-driven solution in clinical trials SUNNYVALE, Calif. and NEWTON, Mass., Dec. 10, 2025 ( [...]
USOSM Surgeon Partners Gave 2,170+ Patients in Africa and Central America More Reasons to Smile through Medical Missions This Year
10/12/2025
IRVING, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- During the past 12 months, U.S. Oral Surgery Management ( USOSM ) surgeon partners and their teams provided free oral care to more than 2,170 patients in Tanzania, Belize [...]
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
10/12/2025
MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri [...]
Branded Legacy, Inc. Announces Complete Management Overhaul and Strategic Reset Under New Leadership
10/12/2025
VANCOUVER, British Columbia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG ) ("the Company") today announced a comprehensive restructuring and change of control following the acquisition [...]
Aeroflow Health and Molina Healthcare Break Down Barriers to Nutrition and Diabetes Care in South Carolina
10/12/2025
The new partnership expands nutrition counseling and DSME services for Molina Commercial and Medicare members statewide to support long-term health outcomes ASHEVILLE, N.C., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Aeroflow [...]
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
10/12/2025
Tom Equels, CEO of AIM ImmunoTech, discusses the unmet need and driving Ampligen forward in pancreatic cancer OCALA, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “ [...]
OneMedNet Reports Strong Momentum and Industry Excitement at RSNA
10/12/2025
MINNEAPOLIS, Dec. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator and provider of one of the world's largest regulatory-grade, AI-ready Real-World Data (RWD) network, today [...]
Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™
10/12/2025
Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company [...]
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
10/12/2025
Clinical trial achieved all three primary objectives with no significant safety issues being reported Results indicate that Emrosi can be safely used for up to 16 weeks with no detectable impact on skin, GI tract or [...]
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
10/12/2025
THE WOODLANDS, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a target for obesity [...]
PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules
10/12/2025
TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]

Pages